Journal
MOLECULAR NEUROBIOLOGY
Volume -, Issue -, Pages -Publisher
SPRINGER
DOI: 10.1007/s12035-023-03758-1
Keywords
Percutaneous coronary intervention (PCI); Anxiety; Depression; Brain-derived neurotrophic factor (BDNF); Biomarker
Categories
Ask authors/readers for more resources
This article reviews the correlation between brain-derived neurotrophic factor (BDNF) and anxiety or depression after percutaneous coronary intervention (PCI), and focuses on the latest research progress of the mechanism of BDNF in anxiety or depression after PCI. It includes the specific mechanisms by which BDNF regulates the levels of inflammatory factors, reduces oxidative stress damage, and mediates multiple signaling pathways. Additionally, this review summarizes the therapeutic potential of BDNF as a potential biomarker for anxiety or depression after PCI.
Anxiety or depression after percutaneous coronary intervention (PCI) is one of the key clinical problems in cardiology that need to be solved urgently. Brain-derived neurotrophic factor (BDNF) may be a potential biomarker for the pathogenesis and treatment of anxiety or depression after PCI. This article reviews the correlation between BDNF and cardiovascular system and nervous system from the aspects of synthesis, release and action site of BDNF, and focuses on the latest research progress of the mechanism of BDNF in anxiety or depression after PCI. It includes the specific mechanisms by which BDNF regulates the levels of inflammatory factors, reduces oxidative stress damage, and mediates multiple signaling pathways. In addition, this review summarizes the therapeutic potential of BDNF as a potential biomarker for anxiety or depression after PCI.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available